Effects of Sesamol on Experimental CisplatinNephrotoxicity Model
| dc.contributor.author | Dilek, Mehmet Emin | |
| dc.contributor.author | Gurel, Alı | |
| dc.contributor.author | Doğantekin, Akif | |
| dc.contributor.author | Şahin, Kazım | |
| dc.contributor.author | Özercan, İbrahim Hanifi | |
| dc.contributor.author | İlhan, Necip | |
| dc.contributor.author | Çeliker, Hüseyin | |
| dc.date.accessioned | 2026-08-12T15:37:10Z | |
| dc.date.issued | 2020 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Aim: Cisplatin causes oxidative damage in the kidney. Sesamol is one of the water-soluble and antioxidant compounds of sesame oil. We investigated the effect of sesamol on experimental cisplatin nephrotoxicity and lipid peroxidation.Material and Method: Twenty-eight male Wistar rats were used in 4 groups (n=7): control, sesamol (8 mg/kg/day), cisplatin (7 mg/kg i.p., single dose), and cisplatin + sesamol. Specimens were evaluated with biochemical, molecular and histopathologic methods. SPSS package programme was used for statistical analyses.Results: Urea and creatinine levels were significantly higher in the cisplatin group compared to the control group and were significantly decreased in the cisplatin+sesamol group (p<0.05). Cisplatin-treated rats showed a significant increase in malondialdehyde (MDA) levels (p<0.05). Sesamol significantly decreased MDA (p<0.05). Nuclear factor kappa B (NF-?B) levels increased in the cisplatin group compared to the control group and decreased significantly in the cisplatin+sesamol group (p<0.001). Nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) levels were decreased in the cisplatin group compared to the control group (p<0.001) and increased significantly in the cisplatin+sesamol group (p<0.01). Histopathological changes with cisplatin decreased with sesamol.Conclusion: We determined that sesamol decreases lipid peroxidation and NF-?B levels and shows antioxidant effect by increasing Nrf2 and HO-1 levels on cisplatin induced nephropathy | |
| dc.identifier.doi | 10.5505/kjms.2020.54227 | |
| dc.identifier.endpage | 187 | |
| dc.identifier.issn | 2146-2631 | |
| dc.identifier.issn | 2587-053X | |
| dc.identifier.issue | 3 | |
| dc.identifier.startpage | 180 | |
| dc.identifier.trdizinid | 423411 | |
| dc.identifier.uri | https://doi.org/10.5505/kjms.2020.54227 | |
| dc.identifier.uri | https://search.trdizin.gov.tr/tr/yayin/detay/423411 | |
| dc.identifier.uri | https://hdl.handle.net/11508/35346 | |
| dc.identifier.volume | 10 | |
| dc.indekslendigikaynak | TR-Dizin | |
| dc.language.iso | en | |
| dc.relation.ispartof | Kafkas Tıp Bilimleri Dergisi | |
| dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.relation.tubitak | info:eu-repo/grantAgreement/TUBITAK// | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_TR-Dizin_20260511 | |
| dc.subject | Genel ve Dahili Tıp | |
| dc.subject | Patoloji | |
| dc.subject | Biyokimya ve Moleküler Biyoloji | |
| dc.title | Effects of Sesamol on Experimental CisplatinNephrotoxicity Model | |
| dc.type | Article |







